Overexpression of GDNF by vector transfection has also shown some efficacy in rodent models [80] contrasting with the lack of clinical benefit after intraputaminal or intracerebroventricular infusions of GDNF in PD patients [92, 93]. This evidence concerns the gene GDNF and Parkinson disease.